Dr. Tam E. Perry is an associate professor at Wayne State University School of Social Work. Her research addresses urban aging from a life course perspective, focusing on how underserved older adults navigate their social and built environments in…
Get the latest news from the 2022 Bleeding Disorders Conference with Friday issue of the NHF Show Daily!Read it now
Get the latest news from the 2022 Bleeding Disorders Conference with the Saturday issue of the NHF Show Daily!Read it now
Aug 28, 2022 FOR IMMEDIATE RELEASE MEDIA CONTACT Ilana Ostrin Senior Director of Public Relations and Communications …
Get the latest news from the 2022 Bleeding Disorders Conference with the Wrap-up issue of the NHF Show Daily!Read it now
A newly released survey of individuals with Hereditary Factor X Deficiency (HFXD) and caregivers of those with HFXD yielded noteworthy insights related to treatment and quality of life (QoL).
The initial data gleaned from HFXD American Survey…
The U.S. Food and Drug Administration has accepted for priority review the Biologics License Application (BLA) for Sanofi’s investigational therapy efanesoctocog alfa (BIVV001).
BIVV001 is a recombinant factor VIII therapy (rFVIII) developed for…
The National Hemophilia Foundation is proud to support the second-annual Telehealth Awareness Week presented by the American Telemedicine Association! Telehealth continues to play a critical role in supporting access to safe, quality healthcare…
The National Hemophilia Foundation (NHF) and Medscape are pleased to announce the first live activity in a Virtual Grand Round Series on “Gene Therapy for Patients with Hemophilia.”
The program, presented through a collaboration between the NHF…
Apply by Sept. 23 to join one of four NBDF task forces focused on health equity, diversity, and inclusion. Task forces include focuses on access, mental health, health system navigation, and payer/policy. Click the button to fill out an application…